Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?
Year: 2020
Type: article
Study design: Observational Study
Source: Annals of Surgical Oncology
Institutions: Massachusetts General Hospital, Harvard University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3024928385